CN104544084B - 一种用于糖尿病患者的保健食品 - Google Patents
一种用于糖尿病患者的保健食品 Download PDFInfo
- Publication number
- CN104544084B CN104544084B CN201510024979.0A CN201510024979A CN104544084B CN 104544084 B CN104544084 B CN 104544084B CN 201510024979 A CN201510024979 A CN 201510024979A CN 104544084 B CN104544084 B CN 104544084B
- Authority
- CN
- China
- Prior art keywords
- semen
- flour
- diabetics
- health food
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 21
- 210000000582 semen Anatomy 0.000 claims abstract description 61
- 235000013312 flour Nutrition 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 27
- 241000255791 Bombyx Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241001620634 Roger Species 0.000 claims abstract description 13
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 12
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 10
- 241000222640 Polyporus Species 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 241000219051 Fagopyrum Species 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 24
- 240000008620 Fagopyrum esculentum Species 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 34
- 239000008280 blood Substances 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 31
- 239000003814 drug Substances 0.000 description 24
- 235000013305 food Nutrition 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 230000002265 prevention Effects 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 8
- 235000017491 Bambusa tulda Nutrition 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 244000082204 Phyllostachys viridis Species 0.000 description 8
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 8
- 241000209140 Triticum Species 0.000 description 8
- 235000021307 Triticum Nutrition 0.000 description 8
- 239000011425 bamboo Substances 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 235000012149 noodles Nutrition 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010012335 Dependence Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- GENAHGKEFJLNJB-QMTHXVAHSA-N Ergine Natural products C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(N)=O)=C3C2=CNC3=C1 GENAHGKEFJLNJB-QMTHXVAHSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000209219 Hordeum Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- GENAHGKEFJLNJB-UHFFFAOYSA-N Lysergsaeure-amid Natural products C1=CC(C2=CC(CN(C2C2)C)C(N)=O)=C3C2=CNC3=C1 GENAHGKEFJLNJB-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000000260 Typha latifolia Species 0.000 description 1
- 235000005324 Typha latifolia Nutrition 0.000 description 1
- 241000608575 Vespertilio Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008195 breast development Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- YDPHSKXTPWQXBA-QMTHXVAHSA-N ergine Chemical compound C1=CC=C2C3=C[C@@H](C(N)=O)CN(C)[C@@H]3CC3=CN=C1[C]32 YDPHSKXTPWQXBA-QMTHXVAHSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- -1 fatty oily 2.5 Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
<b>本发明公开了一种用于糖尿病患者的保健食品,该用于糖尿病患者的保健食品按重量份的主要原料组成是:小麦面粉55-75份,荞麦面粉3-10份,榆树皮粉3-10份,柳树叶粉3-10份,青棵面粉3-10份,青钱柳粉1-3份,赤小豆1-3份,山药2-4份,马齿苋2-4份,肉桂0.5-1份,玉米须0.5-1份,僵蚕0.5-1份,黄芪0.5-1份,丹参0.8-1.5份,当归0.8-1.5份,黄精0.8-1.5份,猪苓0.8-1.5份,拟黑多刺蚁1-3份。该保健食品可为糖尿病患者全面均衡地补充营养物质,增强免疫力,适合各类糖尿病患者食用。</b>
Description
一、技术领域
本发明属于一种药食同源的用于糖尿病患者的保健食品。
二、背景技术
糖尿病是由遗传因素、免疫功能紊乱、微生物感染及其毒素、自由基毒素、精神因素等等各种致病因子作用于机体导致胰岛功能减退而引发的糖、蛋白质、脂肪、水和电解质等一系列代谢紊乱综合症,临床上以高血糖为主要特点,典型病例可出现多尿、多饮、多食、消瘦等表现,即“三多一少”症状。“糖尿病”是一种血液中的葡萄糖容易堆积过多的疾病。国外给它的别名叫“沉默的杀手”,特别是“成人型糖尿病”,四十岁以上的中年人染患率特别高,在日本,四十岁以上的人口中占10%,即十人当中就有一位“糖尿病“患者。一旦患上“糖尿病”,将减少寿命十年之多,且可能发生的并发症遍及全身。糖尿病人的日常饮食有很多禁忌,因此开发研究适合糖尿病人食用的保健食品己经成为医学界和食品研究机构的研究热点之一。
中国专利申请200710166302.6号公开了一种名称为预防和治疗糖尿病的保健食品及其制备方法,该保健食品主要由以下重量份的各原料制成:人参25-80份、马齿苋21-82份、黄连19-72份、山药12-43份、地黄9-15份、山茱萸7-29份、决明子7-52份、蜂胶5-46份和僵蚕多糖5-15份。本发明保健食品食用安全可靠,无任何毒副作用,具有降低血糖,促进胰岛细胞修复等多重功效,可有效预防或治疗II型糖尿病。
中国专利申请200610116111.4号公开了一种名称为糖尿病患者专用营养食品及其制备方法,该发明按重量份计,包含有猪苓8-16份,枸杞8-16份、白扁豆8-16份、赤小豆6-12份、苦荞麦8-16份,筱麦6-12份、甲壳素3-12份、怀山药3-10份,薏苡仁3-10、花生坚果分离蛋白3-12份、乳清浓缩蛋白1-5份、黄精3-10份、玉竹3-10份。上述营养食品中还可含有下列成分中的一种或几种:螺旋藻0.5-2份、低酷果胶0.5-2份、肉桂1-5份、仙人掌1-5份、苦瓜1-5份、茶多酚0.04-0.2份,葡萄糖酸锌0.03-0.05份、亚硒酸钠0.0001-0.0005份、乳钙1-4份、碳酸镁0.2-0.8份、维生素C0.1-0.5份、维生素B10.01-0.05份、维生素B20.01-0.05份。
该发明对糖尿病患者血糖有双向调节作用,帮助糖尿病患者维持血糖的相对稳定,同时可减少饥饿感,并有益于减肥和降低血脂。本发明有营养补充作用,有利于配合糖尿病患者的饮食控制与治疗。
三、发明内容
本发明的目的是克服现有技术的不足,研制一种主要具有药食同源功效的可为人体全面均衡地补充营养物质,增强免疫力,从而达到适合各类糖尿病患者食用的预防糖尿病的保健食品。
本发明是这样实现的:
一种用于糖尿病患者的保健食品,其特征是:该预防糖尿病的食品按重量百分比的主要原料组成是:该用于糖尿病患者的保健食品按重量份的原料组成是:小麦面粉55-75份,荞麦面粉3-10份,榆树皮粉3-10份,柳树叶粉3-10份,青稞面粉3-10份,青钱柳粉1-3份,赤小豆1-3份,山药2-4份,马齿苋2-4份,肉桂0.5-1份,玉米须0.5-1份,僵蚕0.5-1份,黄芪0.5-1份,丹参0.8-1.5份,当归0.8-1.5份,黄精0.8-1.5份,猪苓0.8-1.5份,拟黑多刺蚁1-3份。
小麦面粉60-70份,荞麦面粉4-9份,榆树皮粉4-9份,柳树叶粉5-8份,青稞面粉5-8份,青钱柳粉1.5-2.5份,赤小豆1.5-2.5份,山药2.5-3.5份,马齿苋2.5-3.5份,肉桂0.6-0.9份,玉米须0.6-0.9份,僵蚕0.6-0.9份,黄芪0.6-0.9份,丹参0.9-1.4份,当归0.9-1.4份,黄精0.9-1.4份,猪苓0.9-1.4份,拟黑多刺蚁1.5-2.5份。
所述的山药最好是怀山药。
所述原料为不含水分和杂质的净含量,原料组成的比例可以适当大于或小于上述范围,但以上述范围为宜。
所述的原料组成及含量是经发明人多年探索并在一定范围内的人群中试用后获得的预防糖尿病效果较为理想的保健食品。下面对相关原料的药食特性进行简单介绍:
1.荞麦:营养成分,荞麦起源于我国,是一种古老的粮食作物,《神龙书》中记载,荞麦营养丰富,药谱性高,生产时间短,抗逆性强,是很受群众欢迎的食品,也是制造各种高级食品、蛋糕、糖果的优良原料。荞麦含有70%的淀粉,10.8-11.5%的蛋白质,其含量不低于大米和小麦豆粉,2.5-3%的脂粉,1.3%的维生素,维生素B1;B2的含量比小麦高2倍,赖氨酸、精氨酸、色氨酸等人体必需的氨基酸都很丰富,其中赖氨酸的含量是小麦的2.8倍,荞麦中还富含有丰富的医麦碱,芦丁、烟酸、亚油酸等多种维生素及磷、钾、钙、铁、锌、硒等10余种矿物质和人体必需的微量元素。〔药用功效〕荞麦食品下气利肠,消热解毒,还有很好的降血糖、降血脂、降血压功效。各种做成的食品,是糖尿病患者的保健品,荞麦中含有某种p族维生素,具有抗癌作用外,还有微量元素硒,也有防癌作用。岛国斐济之所以成为“无癌国”,很多人认为是与当地
人多吃荞麦有关。
2、大麦:一年生草本,高60-100厘米。秆直立,光滑无毛。叶鞘无毛,有时基生叶的叶鞘疏生柔毛,叶鞘先瑞两侧具弯曲沟状的叶耳;叶舌小,长约1-2毫米,膜质;叶片扁平,长披针形,长8一18厘米,宽6-18毫米,上面粗糙,下面较平滑。性味,甘咸,凉。
3、筱麦:禾谷类作物。学名裸燕麦。根据播种期早晚分为夏征麦和秋蔽麦。筱麦籽粒瘦长,有腹沟,表面生有茸毛,尤以顶部显著。形状为筒形或纺锤形,筱麦是营养丰富的粮食作物,在禾谷类作物中蛋白质含量最高,且含有人体必需的8种氨基酸,其组成也较平衡。筱麦含糖分少,蛋白多,是糖尿病患者较好的食品。又因脂肪中含有较多的亚油酸,是老年人常用的疗效食品。筱麦的营养价值很高,蛋白质含量平均达15.6,高出大米100、玉米75,小麦面粉66、小米60,8种氨基酸组成较平衡,赖氨酸含量还高于大米和小麦面粉;脂肪和热能都很高,脂肪是大米的5.5倍,小麦面粉的3.7倍。此外,维生素和磷、铁等物质也比较丰富。筱面出粉率高,一般可达九成以上,吃水量大,5公斤筱面可做1公斤成品。
4、青稞:是禾本科大麦属的一种禾谷类作物,因其内外颖壳分离,籽粒裸露,故又称裸大麦、元麦、米大麦。青稞分为白青稞,黑青稞,墨绿色青稞等种类。青稞具有丰富的营养价值和突出的医药保健作用。在高寒缺氧的青藏高原,为何不乏百岁老人,这与常食青稞,与青稞突出的医疗保健功能作用是分不开的。据《本草拾遗》记载:青稞,下气宽中、壮精益力、除湿发汗、止泻。藏医典籍《晶珠本草》更把青稞作为一种重要药物,用于治疗多种疾病。
5、青钱柳粉:别名牛菜、大力子、恶实、青钱柳粉子、蝙蝠刺、东洋萝卜、东洋参、牛鞭菜等。青钱柳粉在日本成为寻常百姓家强身健体,防病治病的保健菜。它可以与人参相媲美,因此被称作东洋参。在我国长期做为药用,近年来才开始对青钱柳粉的营养价值,食用价值和药理进行研究。青钱柳粉的纤维可以促进大肠蠕动,帮助排便,降低体内胆固醇,减少毒素、废物在体内积存,达到预防中风和防治胃癌、子宫癌的功效。西医认为它除了具有利尿、消积、祛痰止泄等药理作用外,还用于便秘、高血压、高胆固醇症的食疗。中医认为有疏风散热、宣肺透疹、解毒利咽等功效。可用于风热感冒、咳嗽痰多、麻疹风疹、咽喉肿痛。《本草经疏》称其为“散风除热解毒三要药”。《本草纲目》称其“通十二经脉,洗五脏恶气”“久服轻身耐老”。我国《现代中药学大辞典》、《中药大辞典》等药典中把青钱柳粉的药理作用概括为:有促进生长作用;有抑制肿瘤生长的物质;有抗菌和抗真菌作用。
6、赤小豆:别名红豆、野赤豆。化学成分含。一、p-球阮(a,I3-globulin)、脂肪酸、烟酸、糖类,维生素A1,B1,B2,植物昌醇、三砧皂试等。性味性平,味甘、酸。功能主治利水消种,解毒排脓。用于水肿胀满、脚气浮肿、黄疽尿赤、风湿热痹、痈肿疮毒、肠痈腹痛。
7.马齿苋:营养成分,马齿苋富含大量的异黄酮活性成分,也是天然的植物激素。它的结构与女性体内的雌激素相似,可以起到模拟、干扰、双向调节内分泌水平的生理生化作用。无臭,味微甜。马齿苋素有“植物黄金”之称,目前,葛粉挂面等己出口到日本诸国。药用功效,(1)马齿苋能有效缓解更看期综合症,又能延年益寿、增进健康,己成为中年女性日常保健、提高生活质量的理想选择。(2)常吃马齿苋,可以帮助促使胸部发育增大;异黄酮具有滋润皮肤、恢复皮肤弹性的作用,能够帮助和支持乳房再现挺拔。(3)马齿苋异黄酮可以减缓骨骼组织细胞的老化,有助于钙质的吸收,减少骨钙丢失,增加骨密度并阻止骨骼的中空消溶,从而远离骨质疏松。(4)马齿苋中的活性成分不仅可以降压、降糖、降脂、预防心脑血管等疾病,而且能够有效调节内分泌水平,营养卵巢,拒绝早哀。(5)马齿苋素可以用来保护血管弹性,降低血管疾病的发生率。
8、山药:营养成分,山药中含有多种微量元素,且含量较为丰富,具有滋补作用,为病后康复食补之佳品。山药还含有丰富的维生素和矿物质,所含热量相对较低。药用功效,山药可促使肌体T淋巴细胞增殖、增强免疫功能,延缓细胞哀老。健脾、益胃、助消化、固肾、益精、益肺止咳、降低血糖等功能。“常服山药延年益寿”的说法是有科学道理的。山药中的勃多糖物质与无机盐类相结合,可以形成骨质,使软骨具有一定弹性。其中:怀山药,中华人民共和国国家质量监督检验检疫总局与中国国家标准化管理委员会于2006年5月25日正式颁布《地理标志产品怀山药(GB\T20351-2006)/中华人民共和国国家标准》,规定为北纬34.48至35.30、东经112.02至113.38之间的地理范围,即河南省焦作市的行政辖区之内,所产的山药,可以使用“怀山药”的国家地理标志产品名称。作为中药最重要的补益材料之一,怀山药与其他常用的补药,如人参、党参、当归等相比,最大的区别,也是它的最大优点,是无任何副作用。因此被历来医家评价为“温补”“性平”,是“药食同源”的典范,即可以当成正常食物充饥使用,用者没有避忌,适宜于任何人群、任何体质,包括老人、儿童、孕妇和其他特殊人群(见2007年中央电视台录制的《山药-神仙之食》节目中,北京中医医院主任医师王国玮对怀山药的评论)。这也是为何怀山药在中药药方中出现频率最高的根本原因。
9.肉桂:营养成分,肉桂味辛、甘、大热。辛热散寒、甘热助阳、温通行滞、作用温和持久,官运亨通而不走。有补火助阳、散寒止痛、温通血脉的功效,运用于肾阳不足、均可起到温补的效果。药用功效近10年国内钻研究文献报道,中药肉桂单方及复方具有降低血糖和调解血脂的作用。浙江中医药大学何岚教授通过小白鼠和临床作用,并建议人们在每天的饮食中适当加入含有肉桂的香料,同时可以粉碎为细粉,每日口服。中药肉桂治疗糖尿病作用己通过临床实践及现代药理研究证明,明确降血糖、降血脂,稳定血糖、血脂水平,长期维持糖化血红蛋白的正常水平作用。肉桂对防治糖尿病及其并发症状、体征、提高患者的生活质量,还是改善血糖、糖化血红蛋白、血脂、血勃、蛋白尿方面都起到较好的作用。
10、玉米须:玉麦须《滇南本草》,玉蜀黍蕊《现代实用中药》,棒子毛(《河北药材》)。化学成分,含脂肪油2.5、挥发油0.12、树胶样物质3.8、树脂2.7、苦味糖试1.15、皂试3.18、生物碱0.05。还含隐黄素、抗坏血酸、泛酸、肌醇、维生素K、谷氨酸醇、苹果酸、柠檬酸、酒石酸、草酸等。药理作用,①利尿作用:玉米须对人或家兔均有利尿作用,可增加氯化物排出量,但作用较弱。其水浸膏甲醇不溶部分经过透析者(甲)利尿作用最强,无论口服、皮下或静脉注射均有显著效果。利尿作用主要是肾外性的,对肾脏的作用很弱。②对循环系统的作用:麻醉犬静脉注射煎剂有显著降压作用,但对慢性颈动脉皮桥狗,每日服药,连续3周,并无降压作用。甲在低浓度时对末梢血管有扩张作用。③降低血糖作用:玉米须的发酵制剂对家兔有非常显著的降低血糖作用。④利胆、止血作用:玉米须制剂能促进胆汁排泄,降低其粘度,减少其胆色素含量,因而可作为利胆药用于无并发症的慢性胆囊炎、胆汁排出障碍的胆管炎患者。它还能加速血液凝固过程,增加血中凝血酶元含量,提高血小板数,故可作为止血药兼利尿药应用于膀肌及尿路结石。
11、僵蚕:营养成份,僵蚕是名贵中药,古代被称作神草。僵蚕中含有多种矿物质,特别是有机锗的含量比其他生物都高。研究认为有机锗能促使血液循环,促进新陈代谢,延缓哀老,强化人体的免疫系统,提高人体的抵抗能力,是滋补强壮、扶正固本的珍贵药物。药用功效,僵蚕性温,味苦涩。历代医书记载僵蚕具有益心气、安神补肝、坚筋骨、利关节、治耳聋等多种功效。近代医学研究认为,尤其在预防哀老和老年性疾病中占有重要地位。僵蚕对慢性支气管炎、冠心病、心绞痛、高山症、慢性肝炎、神经哀弱、心悸头晕等症均有不同程度的疗效,临床上还用于治疗癌症、克山病、胃病、肾病、糖尿病等病症。
12、黄芪,性状本品呈圆锥形,扭曲,长8-25cm,直径1-3cm。表面棕黄色或深黄色,有稀疏的玩状细根痕,上部较粗糙,有扭曲的纵皱或不规则的网纹,下部有顺纹和细皱。质硬而脆,易折断,断面黄色,中间红棕色,通称子答,以清火养阴为主;老根中间呈暗棕色或棕黑色,枯朽状或己成空洞,称枯答,以清火败毒为主。气微,味苦。性味与归经,苦,寒。归肺、胆、脾、大肠、小肠经。功能与主治,清热燥湿,泻火解毒,止血,安胎。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疽,肺热咳嗽,高热烦渴,血热吐蛆,痈肿疮毒,胎动不安。
13、丹参,基原本品为双子叶植物唇形科丹参的干燥根及根茎。性味归经苦,微寒。归心、肝经。功效活血调经,祛疲止痛,凉血消痈,清心除烦,养血安神。主治月经不调,经闭痛经,症瘾积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。用于胸肋胁痛,风湿痹痛,症瘾结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后疲痛等。治疗胸肋疼痛、症瘾结块,以及月经不调、经闭经痛具有良效。用于温病热入营血、身发斑疹、神昏烦躁。常与鲜地黄、水牛角、玄参等药同用。用于心悸怔忡、失眠。常与酸枣仁、柏子仁等药配合同用。
14、当归,当归是名贵中药材,根据药典记载有补气固表、利尿之功效,民间还有冬令取当归配成滋补强身之食品的习惯。味甘,气微温,气薄而味浓,可升可降,阳中之阳也,无毒。专补气。入手太阴、足太阴、手少阴之经。其功用甚多,而其独效者,尤在补血。性味与归经:甘,温。归肺、脾经。功能主治:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便搪,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿当归圆片,痈疽难溃,久溃不敛,血虚疹黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
15、黄精,又名老虎姜、鸡头参。黄精以根茎入药。具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。性味归经,甘,平。归肺,脾,肾经。功能主治,滋肾润脾,补脾斋气。
16,猪苓,药性,甘、淡、平、归肺、胃、肾经。药效,败毒抗癌、利水化饮、健脾宁心。利水渗湿,健脾,化痰,宁心安神。
17.拟黑多刺蚁,营养成分,现代药理研究结果显示,拟黑多刺蚁主要含有:(1)黄酮类:芸香普,榭皮素、异榭皮普,(2)香豆精类:有伞形花内酷,东莫若素、东若普、经基得豆精;(3)植物醇类:p-谷醇及其葡萄糖普、茶油醇、牛膝酮、蜕皮酮;(4)三砧类;(5)羽扇豆醇及腺嘿吟,胆碱胡芦巴碱,内消旋肌醇。(6)微量元素:锰、锌、铜。尤其是所含6-脱氧野民霉素有类似于葡萄糖普酶抑制剂的作用,可以有效降低餐后血糖,所以用于治疗2型糖尿病,尤其是餐后血糖升高为特征者有效。药用功效,按照中医的说法,拟黑多刺蚁味苦甘性寒,归肺、肝经,功效除了能疏散风热可以用于外感冒咳嗽以外,还有清肝明目的作用。李时珍《本草纲目》中更指出:“拟黑多刺蚁及是阳明之药,煎汁代敬,能止消渴。”认为拟黑多刺蚁煮水当茶饮,可以用于治疗糖尿病,实际上也可用于糖尿病视网膜病变眼干眼涩、视物模糊。
药食同源中药材种类繁多,但最有利于防治糖尿病效果较好的有马齿苋、肉桂、猪苓、拟黑多刺蚁、山药、僵蚕等。在本发明中,所述的中药材最好进行超微粉碎后再与相关药食同源食品面粉混合均匀待用。
本发明的优点是:上述具有药食同源功效的预防糖尿病的保健食品对预防糖尿病和改善糖尿病人症状均有明显效果,其加工制作简单可以做成的挂面,馒头,糕点或冲剂等食品,人们食后不仅口感舒适,而且可达到补肾壮阳,补脑提神,健脾养胃,益肺补肝,有利五脏,帮助消化,养容养颜,延缓哀老等作用。尤其是对各类糖尿病患者有着十分重要的滋补和治疗作用。经常食用对降血糖有十分显著的效果,而且对降血脂、降血压、胃溃疡、胃癌、食道癌、肝炎、冠心病、高血压、白血球减少,萎缩性胃炎有明显的预防作用。制成的冲剂携带方便,口感舒适。挂面还具有爽口、柔滑、味鲜美,久煮不浑汤不断条等特点。
实践表明,按上述配比制成的防治糠病挂面、馒头、面点或冲剂等食品,人们食后不仅口感舒适,而且可达到补肾壮阳、补脑提神、健脾养胃、益肺补肝、有利五脏,帮助消化,美容养颜、延缓哀老等作用。尤其是对各类糖尿病有着十分明显的预防作用。所述的防治糖尿病食品生产方法可以是:部分或全部药食同源中药材可以按下列方法制成干粉,或部分用蒸煮方法制成液体拌入上述干粉。
干粉:原料清洗一低温烘干一超微粉碎一杀菌一真空包袋一储藏备用。
液体:小麦面粉、除荞麦面粉、榆树皮粉、柳树叶粉和青稞面粉外,将其余原料通过清洗、蒸煮、过滤后留下液体备用。需使用时,再将小麦面粉、荞麦面粉、榆树皮粉、柳树叶粉和青稞面粉按上述比例混合后加入液体拌匀,按常规方法可制成挂面,鲜面条,糕点,馒头和冲剂等多种食品食用。
四、具体实施方式
实施例1
该用于糖尿病患者的保健食品按重量份的原料组成是:小麦面粉55份,荞麦面粉3份,榆树皮粉3份,柳树叶粉3份,青稞面粉3份,青钱柳粉1份,赤小豆1份,山药2份,马齿苋2份,肉桂0.5份,玉米须0.5份,僵蚕0.5份,黄芪0.5份,丹参0.8份,当归0.8份,黄精0.8份,猪苓0.8份,拟黑多刺蚁1份。
实施例2
该用于糖尿病患者的保健食品按重量份的原料组成是:小麦面粉75份,荞麦面粉10份,榆树皮粉10份,柳树叶粉10份,青稞面粉10份,青钱柳粉3份,赤小豆3份,山药4份,马齿苋4份,肉桂1份,玉米须1份,僵蚕1份,黄芪1份,丹参1.5份,当归1.5份,黄精1.5份,猪苓1.5份,拟黑多刺蚁3份。
Claims (3)
1.一种用于糖尿病患者的保健食品,其特征是:该用于糖尿病患者的保健食品按重量份的原料组成是:小麦面粉55-75份,荞麦面粉3-10份,榆树皮粉3-10份,柳树叶粉3-10份,青稞面粉3-10份,青钱柳粉1-3份,赤小豆1-3份,山药2-4份,马齿苋2-4份,肉桂0.5-1份,玉米须0.5-1份,僵蚕0.5-1份,黄芪0.5-1份,丹参0.8-1.5份,当归0.8-1.5份,黄精0.8-1.5份,猪苓0.8-1.5份,拟黑多刺蚁1-3份。
2.根据权利要求1所述的用于糖尿病患者的保健食品,其特征是:小麦面粉60-70份,荞麦面粉4-9份,榆树皮粉4-9份,柳树叶粉5-8份,青稞面粉5-8份,青钱柳粉1.5-2.5份,赤小豆1.5-2.5份,山药2.5-3.5份,马齿苋2.5-3.5份,肉桂0.6-0.9份,玉米须0.6-0.9份,僵蚕0.6-0.9份,黄芪0.6-0.9份,丹参0.9-1.4份,当归0.9-1.4份,黄精0.9-1.4份,猪苓0.9-1.4份,拟黑多刺蚁1.5-2.5份。
3.根据权利要求1或2所述的用于糖尿病患者的保健食品,其特征是:所述的山药是怀山药。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510024979.0A CN104544084B (zh) | 2015-01-19 | 2015-01-19 | 一种用于糖尿病患者的保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510024979.0A CN104544084B (zh) | 2015-01-19 | 2015-01-19 | 一种用于糖尿病患者的保健食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104544084A CN104544084A (zh) | 2015-04-29 |
CN104544084B true CN104544084B (zh) | 2016-06-08 |
Family
ID=53062006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510024979.0A Active CN104544084B (zh) | 2015-01-19 | 2015-01-19 | 一种用于糖尿病患者的保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104544084B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106492006A (zh) * | 2016-10-25 | 2017-03-15 | 桂林淮安天然保健品开发有限公司 | 一种治疗糖尿病的保健品及其制备方法 |
CN106912921A (zh) * | 2017-01-18 | 2017-07-04 | 恩施硒域传奇健康管理有限公司 | 一种糖尿病全营养配方食品 |
CN106901149A (zh) * | 2017-02-28 | 2017-06-30 | 黄光生 | 一种治疗特定糖尿病的膳食及其食用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101695376B (zh) * | 2009-10-14 | 2012-05-30 | 寇开勤 | 预防糖尿病的保健食品 |
CN102266520B (zh) * | 2011-07-25 | 2013-10-02 | 王保江 | 一种治疗糖尿病的中药组合物 |
JP6051463B2 (ja) * | 2012-11-30 | 2016-12-27 | 日本製粉株式会社 | 小麦粉組成物 |
CN103446503A (zh) * | 2013-07-26 | 2013-12-18 | 杨德俊 | 一种治疗ⅱ型糖尿病的中药组合物 |
CN103445082B (zh) * | 2013-08-29 | 2015-11-18 | 宁夏天瑞产业集团现代农业有限公司 | 一种复配苦荞保鲜面及其制备方法 |
CN103520370B (zh) * | 2013-10-23 | 2015-05-27 | 蒙思瑾 | 一种降血糖的药物 |
-
2015
- 2015-01-19 CN CN201510024979.0A patent/CN104544084B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104544084A (zh) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN102160573B (zh) | 一种代餐奶昔及其制备方法 | |
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
CN102986887A (zh) | 一种养生风味奶昔及其制备方法 | |
CN103053748A (zh) | 一种葛根降脂降糖保健茶及其制备方法 | |
CN105851806A (zh) | 一种甲子米 | |
CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
CN102919450B (zh) | 一种五谷浸提液凉茶及其制备方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN103027155A (zh) | 一种桑叶降脂降压保健茶及其制备方法 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN106562428A (zh) | 一种美颜美体膏滋及其制备方法 | |
CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
CN102940153A (zh) | 一种改善肉质、蛋质的家禽饲料 | |
CN103555530A (zh) | 百合保健药酒 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN101455379A (zh) | 一种适用于糖尿病患者的营养食品及其制备方法 | |
KR20130063074A (ko) | 당뇨병과 당뇨합병증의 혈당 혈압 저하작용 조성물 | |
CN104544084B (zh) | 一种用于糖尿病患者的保健食品 | |
CN101946895A (zh) | 一种以泥鳅为主料的功能食品及其制备方法 | |
CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200515 Address after: 110000 2-7-1, No. 23-1, Liaohe Street, Huanggu District, Shenyang City, Liaoning Province Patentee after: Lu Guang Address before: Fengyang County town of Anhui city in Chuzhou province 233100 yuan ban Road No. 154 unit 3, Room 501 Patentee before: Sun Ning |
|
TR01 | Transfer of patent right |